Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" ?g. }

• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.
• OBJECT label "a significantly shorter , total duration of oxygen supplementation , ( 10 , 45 d , vs , 21 , 61 , d , , P - value=0 , 003 ) and length of stay in the hospital ( 19 76 d , vs 27 , 21 , d , , P - value=0 , 013 ) , However , , extracorporeal membrane , oxygenation and in - hospital mortality rates were not significantly different between groups that received dexamethasone either within 24 hours of hypoxemia ( early , dexamethasone , group ) or 24 hours" provenance.